ALIVUS / NSE / Biotechnology & Drugs
Alivus Life Sciences
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High1,149
Target Low830
Target Mean1.5
Target Median62.5
Risk Metrics
Overall RiskBalanced risk
Board Risk25.72
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Alivus Life Sciences schedules investor meets for June 09 scanx.trade
Half Yearly Results, Half yearly Earnings for Glenmark Life The Economic Times
Number of shareholders of Alivus Life Sciences Ltd – NSE:ALIVUS TradingView
Alivus Life Sciences Downgraded to Hold Amid Mixed Technical and Valuation Signals Markets Mojo
Alivus Life Sciences Ltd Sees Shift in Technical Momentum Amid Mixed Indicator Signals Markets Mojo
Alivus Life Sciences Ltd Surges 7.06% to Day's High of Rs 1123 — Outperforms Sector by 7.21 Percentage Points Markets Mojo
Alivus Life Sciences Ltd Sees Bullish Momentum Shift Amid Technical Upgrades Markets Mojo
Alivus Life Sciences Ltd Valuation Shifts Signal Attractive Investment Opportunity Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026

